Evaluation of cardiovascular risk by growth-differentiation factor-15 and tissue Doppler imaging in children with subclinical hypothyroidism

被引:5
|
作者
Arslan, Derya [1 ]
Buyukinan, Muammer [2 ]
Uysal, Celil [3 ]
Deniz, Cigdem Damla [4 ]
机构
[1] Konya Training & Res Hosp, Univ Hlth Sci, Dept Pediat Cardiol, Konya, Turkey
[2] Konya Training & Res Hosp, Dept Pediat Endocrinol, Konya, Turkey
[3] Patnos State Hosp, Dept Pediat, Agri, Turkey
[4] Konya Training & Res Hosp, Dept Biochem, Konya, Turkey
关键词
Subclinical hypothyroidism; Cardiovascular risk; GDF-15; Child; HEART-FAILURE; GUIDELINES; ECHOCARDIOGRAPHY; ASSOCIATION; CHILDHOOD; HORMONE; DISEASE;
D O I
10.1007/s12020-019-01933-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Subclinical hypothyroidism, defined as increased TSH serum levels and normal serum free T4 concentrations, has been associated with an increased risk of heart disease in adults. But, data in children and adolescents are scanty and treatment of subclinical hypothyroidism is controversial. Growth differentiation factor-15 (GDF-15) is a promising biomarker of cardiac remodeling. This study aimed to evaluate the cardiovascular risk factors in children with subclinical hypothyroidism, measured with tissue Doppler echocardiography (TDE), and conventional echocardiography and GDF-15 level. Methods The study comprised a total of 41 pediatric patients with subclinical hypothyroidism (SH) (mean age 9.6 +/- 4.7 years) and 31 healthy children (mean age 11.2 +/- 3.4 years) as the control group. Subclinical hypothyroidism was defined as a thyroid-stimulating hormone level higher than 4 mIU/l and a normal free-thyroxine level (0.6-1.8 ng/dl). Tissue Doppler echocardiography was performed to all individuals in the control group and patient group at the beginning of the study. Global systolic function as assessed by left ventricular ejection fraction was compared between groups. The serum GDF-15 level was measured. Results There were no significant differences in demographic parameters between the SH and control groups. The left ventricular internal diameter end systole, interventricular septal end diastole, left ventricular posterior wall end diastole, and tricuspid annular plane systolic excursion values were significantly different between the SH and control groups (p = 0.038, 0.028, 0.005, and 0.000, respectively). The mean mitral isovolumic relaxation time value of the SH group was 57.2 +/- 9.3 ms, compared to 44.5 +/- 5.6 ms for the control group (p = 0.000). The mean tricuspid isovolumic contraction time value of the SH group was 58.7 +/- 9.4 ms, and that of the control group was 45.1 +/- 5.3 ms (p = 0.000). The mean tricuspid isovolumic relaxation time value of the SH group was 58.03 +/- 9.5 ms, and that of the control group was 45.1 +/- 5.3 ms (p = 0.000). There were no significant differences in the other m-mode or pulse Doppler echocardiography values between two groups. The GDF-15 value of the SH group was 382.6 +/- 268.2 pg/mL, and that of the control group was 473.6 +/- 337.9 pg/mL; this difference was not significant. Conclusion Patients with subclinical hypothyroidism versus healthy individuals had some changes in echocardiographic parameters that indicate involvement of diastolic function of the left ventricle. They were significantly different when compared SH group and the control group. This study demonstrated ventricle diastolic dysfunction in pediatric patients with hypothyroidism. The results of our study suggest that cardiac follow-up may be useful in patients with subclinical hypothyroidism and clinical trials are needed to explore therapeutic effects of T4 and T3 administration in this patients.
引用
收藏
页码:601 / 607
页数:7
相关论文
共 50 条
  • [21] Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction
    Kempf, Tibor
    Bjoerklund, Erik
    Olofsson, Sylvia
    Lindahl, Bertil
    Allhoff, Tim
    Peter, Timo
    Tongers, Jorn
    Wollert, Kai C.
    Wallentin, Lars
    EUROPEAN HEART JOURNAL, 2007, 28 (23) : 2858 - 2865
  • [22] Growth-differentiation factor-15 and functional outcome after acute ischemic stroke
    Groeschel, Klaus
    Schnaudigel, Sonja
    Edelmann, Frank
    Niehaus, Cord-Friedrich
    Weber-Krueger, Mark
    Haase, Beatrice
    Lahno, Rosine
    Seegers, Joachim
    Wasser, Katrin
    Wohlfahrt, Janin
    Vollmann, Dirk
    Stahrenberg, Raoul
    Wachter, Rolf
    JOURNAL OF NEUROLOGY, 2012, 259 (08) : 1574 - 1579
  • [23] Prognostic utility of growth-differentiation factor-15 in patients with chronic heart failure
    Kempf, T.
    Von Haehling, S.
    Cicoira, M.
    Ponikowski, P.
    Filippatos, G. S.
    Rozentryt, P.
    Anker, S. D.
    Wollert, K. C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 6 : 46 - 47
  • [24] Growth-Differentiation Factor-15 is an Independent Predictor of Cardiovascular Events and Mortality in Patients with Stable Coronary Artery Disease
    Kempf, Tibor
    Sinning, Jan-Malte
    Quint, Anja
    Bickel, Christoph
    Sinning, Christoph
    Wild, Philipp S.
    Schnabel, Renate
    Lubos, Edith
    Rupprecht, Hans J.
    Muenzel, Thomas
    Drexler, Helmut
    Blankenberg, Stefan
    Wollert, Kai C.
    CIRCULATION, 2008, 118 (18) : S1132 - S1132
  • [25] Growth-Differentiation Factor-15 Is an Independent Prognostic Indicator in Idiopathic Pulmonary Arterial Hypertension
    Kempf, Tibor
    Nickel, Nils
    Tapken, Heike
    Tongers, Joern
    Laenger, Florian
    Lehmann-Muehlenhoff, Ulrich
    Golpon, Heiko
    Wilkins, Martin R.
    Gibbs, J. Simon R.
    Hoeper, Marius M.
    Wollert, Kal C.
    CIRCULATION, 2008, 118 (18) : S1073 - S1073
  • [26] Growth-differentiation factor-15 is a new powerful biomarker in patients with chronic heart failure
    Kempf, Tibor
    von Haeling, Stephan
    Peter, Timo
    Klein, Gunnar
    Drexler, Helmut
    Anker, Stefan D.
    Wollert, Kai C.
    CIRCULATION, 2006, 114 (18) : 721 - 721
  • [27] Growth Differentiation Factor-15 and Risk of CKD Progression
    Nair, Viji
    Robinson-Cohen, Cassianne
    Smith, Michelle R.
    Bellovich, Keith A.
    Bhat, Zeenat Yousuf
    Bobadilla, Maria
    Brosius, Frank
    de Boer, Ian H.
    Essioux, Laurent
    Formentini, Ivan
    Gadegbeku, Crystal A.
    Gipson, Debbie
    Hawkins, Jennifer
    Himmelfarb, Jonathan
    Kestenbaum, Bryan
    Kretzler, Matthias
    Magnone, Maria Chiara
    Perumal, Kalyani
    Steigerwalt, Susan
    Ju, Wenjun
    Bansal, Nisha
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (07): : 2233 - 2240
  • [28] GROWTH-DIFFERENTIATION FACTOR-15 PREDICTS CARDIOVASCULAR OUTCOMES IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE (THE HEART AND SOUL STUDY)
    Schopfer, David W.
    Regan, Mathilda
    Whooley, Mary
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1475 - E1475
  • [29] GROWTH DIFFERENTIATION FACTOR-15 AND CARDIOVASCULAR DISEASE IN THALASSEMIA INTERMEDIA
    Tantawy, A.
    Adly, A. A.
    Ismail, E.
    Yousef, O.
    Ali, M.
    HAEMATOLOGICA, 2015, 100 : 598 - 598
  • [30] Growth Differentiation Factor-15: a New Biomarker in Cardiovascular Disease
    Kempf, Tibor
    Wollert, Kai C.
    HERZ, 2009, 34 (08) : 594 - 599